The short-read sequencing market is booming, with a CAGR of 16.4% projected to 2033. Driven by personalized medicine, oncology, and NGS advancements, this $7.9B (2025) market offers significant investment opportunities. Learn about key players, market trends, and future growth projections.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.